McKesson Corporation (MCK)
NYSE: MCK · Real-Time Price · USD
714.97
+0.09 (0.01%)
Jun 4, 2025, 12:20 PM - Market open
McKesson Employees
McKesson had 51,000 employees as of March 31, 2023. The number of employees decreased by 24,000 or -32.00% compared to the previous year.
Employees
51,000
Change (1Y)
-24,000
Growth (1Y)
-32.00%
Revenue / Employee
$7,040,216
Profits / Employee
$64,608
Market Cap
89.45B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Mar 31, 2023 | 51,000 | -24,000 | -32.00% |
Mar 31, 2022 | 75,000 | -1,000 | -1.32% |
Mar 31, 2021 | 76,000 | -4,000 | -5.00% |
Mar 31, 2020 | 80,000 | 0 | - |
Mar 31, 2019 | 80,000 | 2,000 | 2.56% |
Mar 31, 2018 | 78,000 | 0 | - |
Mar 31, 2017 | 78,000 | 10,000 | 14.71% |
Mar 31, 2016 | 68,000 | -2,400 | -3.41% |
Mar 31, 2015 | 70,400 | 27,600 | 64.49% |
Mar 31, 2014 | 42,800 | -700 | -1.61% |
Mar 31, 2013 | 43,500 | 5,800 | 15.38% |
Mar 31, 2012 | 37,700 | 1,300 | 3.57% |
Mar 31, 2011 | 36,400 | 3,900 | 12.00% |
Mar 31, 2010 | 32,500 | 0 | - |
Mar 31, 2009 | 32,500 | -400 | -1.22% |
Mar 31, 2008 | 32,900 | 1,100 | 3.46% |
Mar 31, 2007 | 31,800 | 5,400 | 20.45% |
Mar 31, 2006 | 26,400 | 1,200 | 4.76% |
Mar 31, 2005 | 25,200 | 600 | 2.44% |
Mar 31, 2004 | 24,600 | 100 | 0.41% |
Mar 31, 2003 | 24,500 | 500 | 2.08% |
Mar 31, 2002 | 24,000 | 1,000 | 4.35% |
Mar 31, 2001 | 23,000 | 1,900 | 9.00% |
Mar 31, 2000 | 21,100 | -3,500 | -14.23% |
Mar 31, 1999 | 24,600 | 10,900 | 79.56% |
Mar 31, 1998 | 13,700 | 400 | 3.01% |
Mar 31, 1997 | 13,300 | 2,000 | 17.70% |
Mar 31, 1996 | 11,300 | -900 | -7.38% |
Mar 31, 1995 | 12,200 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
MCK News
- 1 day ago - McKesson Corporation Completes Acquisition of Core Ventures - Business Wire
- 17 days ago - McKesson: Sustained Rally Backed By Strong Financials - Seeking Alpha
- 18 days ago - Our Top 10 High-Growth Dividend Stocks -- May 2025 - Seeking Alpha
- 19 days ago - McKesson To Spin-Off Its Medical-Surgical Solutions Business - Forbes
- 21 days ago - McKesson Corporation (MCK) CFO Britt Vitalone Hosts BofA Securities 2025 Healthcare Conference (Transcript) - Seeking Alpha
- 25 days ago - McKesson: Spinoff Of Medical-Surgical Solutions Is A Positive, Strong Buy - Seeking Alpha
- 26 days ago - McKesson Corporation (MCK) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 26 days ago - McKesson to spin off surgical supplies unit, forecasts strong annual profit - Reuters